2-naphthoylethyltrimethylammonium has been researched along with dimethyl fumarate in 1 studies
| Studies (2-naphthoylethyltrimethylammonium) | Trials (2-naphthoylethyltrimethylammonium) | Recent Studies (post-2010) (2-naphthoylethyltrimethylammonium) | Studies (dimethyl fumarate) | Trials (dimethyl fumarate) | Recent Studies (post-2010) (dimethyl fumarate) |
|---|---|---|---|---|---|
| 13 | 0 | 9 | 1,047 | 71 | 886 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jacobo, SA; Kumar, V; LaJevic, M; Malhotra, SV; Pandrala, M; Zabel, BA | 1 |
1 other study(ies) available for 2-naphthoylethyltrimethylammonium and dimethyl fumarate
| Article | Year |
|---|---|
Novel CMKLR1 Inhibitors for Application in Demyelinating Disease.
Topics: Animals; Cell Line, Tumor; Dimethyl Fumarate; Encephalomyelitis, Autoimmune, Experimental; Female; Hepatocytes; Humans; Immunosuppressive Agents; Mice; Mice, Inbred C57BL; Microsomes, Liver; Naphthalenes; Pregnane X Receptor; Quaternary Ammonium Compounds; Receptors, Chemokine; Structure-Activity Relationship | 2019 |